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Summary 
 
We investigated the pathogenesis of pneumococcal pneumonia using clinical 
samples. Results demonstrated that pneumococci in the lung originated from the 
nasopharynx and suggested that changes in pneumococcal gene expression in the 
lung are a feature of pneumococcal pneumonia.
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Abstract 
We investigated the pathogenesis of pneumococcal pneumonia using clinical 
specimens collected for pneumonia surveillance in The Gambia. Lung aspirates and 
nasopharyngeal swabs from 31 patients were examined by culture, qPCR, whole 
genome sequencing, serotyping, and reverse transcription qPCR. Five lung aspirates 
cultured pneumococci, with a matching strain identified in the nasopharynx. Three 
virulence genes including ply (pneumolysin) were upregulated >20-fold in the lung 
compared with the nasopharynx. Nasopharyngeal pneumococcal density was higher in 
pediatric pneumonia patients compared with controls (p <0.0001). Findings suggest that 
changes in pneumococcal gene expression occurring in the lung environment may be 
important in pathogenesis. 
Keywords: pneumonia, Streptococcus pneumoniae, pneumococcus, lung, nasopharynx, 
gene expression 
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Background 
Streptococcus pneumoniae (the pneumococcus) is a common cause of community-
acquired pneumonia, a major public health problem that primarily affects young children 
and the elderly. Pneumococcal pneumonia is believed to occur when pneumococci 
colonising the upper respiratory tract are aspirated into the lung, where a failure to clear 
the bacteria leads to replication and triggers a damaging immune response. Supporting 
clinical data are limited as lung aspirates are not routinely collected in most settings, 
however a previous study from the Gambia found that 85% of paediatric pneumonia 
patients with pneumococci identified in lung aspirates had the same serotype detected 
in a nasopharyngeal swab.[1] Studies have found higher pneumococcal loads in the 
nasopharynx in children with pneumonia compared with healthy controls, suggesting 
that increased pneumococcal density in the nasopharynx may facilitate bacterial spread 
to the lung, or alternatively, may be due to pneumonia.[2, 3] The processes by which 
pneumococci transition from a colonising to a pathogenic state are not well understood. 
Pneumococci possess a variety of virulence factors, including polysaccharide capsule, 
the toxin pneumolysin, adhesins, and surface proteins that allow them to cause 
disease.[4] Examining pneumococcal gene expression in a range of in vitro conditions 
designed to mimic host microenvironments, Aprianto et al. identified 498 conditionally-
expressed genes, highlighting the dynamic transcriptional ability of the 
pneumococcus.[5] Experiments using animal models demonstrated that the 
pneumococcus modifies its gene expression in response to different niches within the 
host.[6, 7] To date, only a single published study has examined pneumococcal gene 
expression in clinical samples. Using nasopharyngeal swabs collected from healthy 
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children, Sakai and colleagues found different levels of expression for 11 pneumococcal 
genes, demonstrating the feasibility of evaluating pneumococcal gene expression 
directly from clinical samples.[8]  
Using a unique set of samples collected as part of pneumonia surveillance in The 
Gambia, we sought to investigate the pathogenesis of pneumococcal pneumonia by 
comparing pneumococcal loads in the nasopharynx of pneumonia patients and healthy 
carriers, conducting whole genome sequencing of paired pneumococcal isolates 
obtained from the nasopharynx and lung of pneumonia patients, and analysing 
pneumococcal gene expression directly from nasopharyngeal swabs and lung 
aspirates.  
Methods 
Detailed methods are provided in the supplementary information.   
This study was nested within population-based surveillance for suspected pneumonia, 
septicaemia, and meningitis among patients aged 2 months or greater in the Basse 
Health and Demographic surveillance system in The Gambia, as described 
previously.[9] All patients with suspected pneumonia who had a lung aspiration from 
April 2015 - May 2016 were included in this study. Nasopharyngeal swabs were 
collected from pneumonia patients and community controls. For all swabs and lung 
aspirates, an aliquot for RNA analysis was prepared by adding 2-fold volume of 
RNAprotect Bacteria Reagent (Qiagen) to the clinical sample.  
The surveillance project and this sub-study were approved by the Gambia 
Government/Medical Research Council Joint Ethics Committee (approval numbers 
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/article-abstract/doi/10.1093/infdis/jiaa186/5823762 by St G
eorge's U
niversity of London user on 23 April 2020
Ac
ce
pte
d M
an
us
cri
pt
 
7 
 
7 
1087 and L2016.09v2). Patients or their parent or guardian provided written informed 
consent for enrolment in the surveillance project and lung aspiration. 
Laboratory procedures 
In brief, nasopharyngeal swab samples underwent DNA extraction and lytA real-time 
quantitative PCR (qPCR) to detect and quantify pneumococci. Pneumococcal density 
data are reported as genome equivalents/ml (GE/ml). Molecular serotyping by 
microarray was conducted on nasopharyngeal swabs. Pneumococci isolated from the 
lung and nasopharynx were serotyped by traditional antibody-based methods and whole 
genome sequencing conducted using the MiSeq platform. Expression of nine 
pneumococcal genes selected from the literature was examined by reverse transcription 
qPCR (RT-qPCR) following RNA extraction from clinical specimens. Genes and primer 
sequences are provided in Supplementary Table 1.  
Data analysis was performed using STATA version 15.1 and GraphPad Prism version 
7.03. Categorical data were compared using the chi-squared test. Pneumococcal 
density data were log10 transformed prior to analysis and examined using non-
parametric methods. Densities were compared using the Mann-Whitney test, and 
multivariable quantile regression models included age, sex, and PCV status as 
variables selected a priori.  
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Results 
Samples from 31 pneumonia patients enrolled in surveillance were included in this 
study. Patient ages ranged from 2 months to 73 years, with a median of 3.8 years (IQR 
1.7, 7.0). The majority were children, with 20 (65%) aged <5 years, six (19%) from 5 – 
18 years, and five (16%) >18 years, and 20/31 (65%) were male. Examination of 
nasopharyngeal swabs from patients of all ages found that 27 (87%) contained 
pneumococci. We compared the prevalence, density, and serotypes of pneumococci in 
the nasopharynx of patients <5 years of age with community controls. Participant 
characteristics are shown in Supplementary Table 2. Pneumococcal prevalence was 
similar in pneumonia patients (18/20; 90%) and community controls (21/22, 96%, 
p=0.493, chi-squared test). Among children with pneumococci detected in the 
nasopharynx, median density was higher in pneumonia patients (7.77 log10 GE/ml; IQR 
7.33, 7.98) compared with controls (6.05; IQR 5.67, 6.47; p <0.0001). When adjusted for 
age, sex, and PCV status, the difference remained significant, with a coefficient 
(difference between medians) of 1.61 log10 GE/ml (95%CI 0.96, 2.26), p < 0.001. 
Serotypes identified in nasopharyngeal swabs from pneumonia patients and controls 
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are shown in Figure 1. Eight serotypes were found in both participant groups, with eight 
additional serotypes found only in pneumonia patients and 11 only found in community 
controls.  
Culture of lung aspirates from 31 pneumonia patients of all ages identified pneumococci 
as the causative organism in five patients (serotypes 3, 14, 1, 12F, and 32A; n=1 each), 
and Staphylococcus aureus in one. All five patients who had pneumococci cultured from 
the lung aspirate had the same serotype identified in their nasopharyngeal swab. 
Pneumococcal lytA qPCR was conducted for the lung aspirates with sufficient volume 
remaining for analysis (n=25). Ten (40%) lung aspirates tested positive by qPCR, 
including the five samples that were also positive by culture. Median pneumococcal 
density was higher in the culture-positive lung aspirates (5.74 log10 GE/ml; IQR 4.93, 
5.93) compared with the culture-negative lung aspirates (3.32 log10 GE/ml; IQR 2.86, 
3.88; p = 0.008). 
To identify within-host genomic changes, in particular DNA mutations that may 
contribute to pneumococcal pathogenesis, whole genome sequencing was conducted 
on the five paired pneumococcal isolates from the lung and nasopharynx of the same 
patient. For all five patients, the isolate from the nasopharynx was the same as that 
from the lung, with >99% sequence similarity and matching multilocus sequences types 
(Supplementary Table 3). Three mutations were identified in isolates from lung 
aspirates (Supplementary Table 4). 
We investigated differences in pneumococcal gene expression by examining RNA 
extracted directly from nasopharyngeal swabs and lung aspirates from the same five 
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patients. Following evaluation of RNA concentration and quality, samples containing 
serotype 3 were excluded from analysis due to DNA contamination, and samples 
containing serotype 14 were excluded due to insufficient RNA yield from the lung 
aspirate. Differences in expression of nine genes in the lung aspirate compared with the 
nasopharynx are shown in Figure 2. Virulence genes ply (pneumolysin), nanA 
(neuraminidase A), and the putative virulence regulator yeeN were consistently and 
strongly upregulated (fold change > 20) in the lung compared to the nasopharynx. In 
contrast, psaB (pneumococcal surface antigen B), endA (endonuclease) and the 
quorum sensing gene luxS were upregulated to a lesser extent, or varied by strain. 
Genes encoding pyruvate oxidase and enolase (spxB and eno, respectively) were 
downregulated in the lung, most prominently in serotype 1. Expression of lytA 
(autolysin) was downregulated in 12F but upregulated in serotypes 1 and 32A.  
Discussion 
We investigated the microbiological features of pneumococcal pneumonia using a 
unique set of clinical specimens obtained as part of pneumonia surveillance in The 
Gambia. This is a high pneumococcal carriage setting, reflected in the high colonization 
rates observed in both pneumonia patients and community controls. In children under 
five years of age, pneumococcal densities in the nasopharynx were over 1 log higher in 
pneumonia patients compared with controls. These results are consistent with data from 
Vietnam and the multi-centre Pneumonia Etiology Research for Child Health (PERCH) 
study.[2, 3] Using whole genome sequencing, we demonstrated that pneumococci 
present in the lung of pneumonia patients originated from the nasopharynx. Although 
our study numbers were small, a previous study in The Gambia found the same 
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serotype in the nasopharynx and lung for 23 of 27 pneumonia cases.[1] A multicentre 
study of children <5 years hospitalized for pneumonia reported that for 34 cases with 
pneumococci detected in blood, 27 (79%) had the same serotype detected in the 
nasopharynx.[10] Combined, these findings provide further evidence that pneumococcal 
pneumonia originates from bacteria present in the upper respiratory tract, and suggest 
that sampling the nasopharynx may provide some insight into pneumonia aetiology.  
A major finding from our study is that few DNA mutations were acquired by the 
pneumococcus during disease, whereas prominent differences in pneumococcal gene 
expression were observed between the lung and the nasopharynx. Although it is 
possible that mutations, for example in the psaB promoter region, may have impacted 
virulence, our results suggest that transcriptional differences rather than genomic 
changes underpin pneumococcal pathogenesis within the host. The ply gene, which 
encodes the pore-forming toxin pneumolysin, was strongly upregulated in the lung for all 
three isolates examined. Expression of endA, which encodes an endonuclease that 
degrades neutrophil extracellular traps (NETs) was upregulated in the lung, whereas 
eno, which encodes an enolase that can induce NET formulation, was 
downregulated.[11, 12] These results suggest that avoidance of NETs may facilitate 
pneumococcal survival in the lung. SpxB has been linked to multiple pneumococcal 
activities, including virulence, colonization, capsule synthesis, and transmission. 
Downregulation of spxB in the lung may relate to one of these functions or its metabolic 
role in oxygen sensing and carbon source utilization.[13] Interestingly, the serotype 1 
isolate displayed the most prominent changes in gene expression in the lung. This 
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isolate belongs to sequence type 3081, a clone that is the leading cause of invasive 
pneumococcal disease in The Gambia and is highly virulent in animal models.[14]  
Viral testing was not conducted as part of this study. Not all lung aspirates underwent 
lytA qPCR, and serotyping was not conducted on the five culture-negative, lytA-positive 
lung aspirates. One key limitation is that gene expression studies were restricted to 
three paired specimens. We did not evaluate the expression of capsule, an important 
virulence factor. Certain capsular serotypes have been linked to pneumonia: serotypes 
1, 5, 22F, 7F, and 14 were more likely to be found in the nasopharynx of children with 
pneumonia than in healthy controls in a study conducted prior to PCV use.[15] A similar 
study conducted in a post-PCV population would provide useful data for consideration 
of serotype coverage of next-generation PCVs. Although our sample size was small, 
data suggested a differing serotype distribution between pneumonia patients and 
community carriers, with serotypes 1 and 5 identified solely in patients.  
There is a paucity of data on pneumococcal gene expression from clinical samples, with 
one study to date examining pneumococcal RNA in the nasopharynx of healthy 
carriers.[8] Due to technical challenges, only three paired samples from our study were 
suitable for analysis of pneumococcal gene expression. Nevertheless, this study 
represents a proof-of-concept for conducting pneumococcal gene expression analysis 
directly from patient clinical specimens, identifying considerable changes in expression 
that occur within the lung. Although we hypothesize that the lung environment triggered 
these changes, other factors may have facilitated pneumococcal spread to the lung, and 
evaluating additional isolates is warranted. Importantly, specimens were stored in an 
RNA stabilizing reagent promptly after collection. Future studies may expand upon the 
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current findings by examining other sample types, such as sputum or pleural fluid, or 
applying transcriptomic approaches such as RNA-seq to examine global changes in 
pneumococcal gene expression. In an experimental model, dual-RNA seq has been 
used to identify transcriptional changes in both pneumococci and the host associated 
with pneumococcal invasion into the pleural space.[6] The identification of molecular 
signatures associated with pneumococcal pneumonia could inform development of 
novel diagnostics and protein-based vaccines. We envision that future studies building 
upon this approach will extend our understanding of the pathogenesis of pneumococcal 
pneumonia. 
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Figure legends 
Figure 1. Mirror plot of pneumococcal serotypes identified in nasopharyngeal swabs of 
children < 5 years of age hospitalised with pneumonia (orange bars) compared with 
pneumococcal serotypes found in nasopharyngeal swabs collected from community 
controls (blue bars).  NT3b refers to a lineage of nonencapsulated Streptococcus 
pneumoniae.  
Figure 2. Differential expression of pneumococcal genes in lung aspirates compared 
with nasopharyngeal swabs collected from the same patient by RT-qPCR. Fold change 
in gene expression was derived using the 2-ΔΔCt method with gyrA as the reference 
gene. Each bar represents data from one gene in one set of patient samples. * indicates 
an imputed Ct value of 40 used for the lung aspirate sample. For serotype 12F, data for 
nanA are not available as no transcripts were detected in either sample. 
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Figure 1 
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Figure 2 
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